A Versatile Simple Capture Assay for Assessing the Structural Integrity of MHC Multimer Reagents

Brendan K Reed1, Laura B Chopp1, Courtney S Malo1

  • 1Department of Immunology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, United States of America.

Plos One
|September 22, 2015
PubMed

Insights

Researchers developed a new method to check the structural integrity of MHC:peptide multimers. This quality control assay ensures accurate visualization of T cell responses, especially with limited or irreplaceable samples.

Area of Science:

  • Immunology and Molecular Biology
  • Biotechnology and Reagent Development

Background:

  • Major Histocompatibility Complex (MHC):peptide multimers are essential tools for visualizing antigen-specific T cell responses.
  • Assessing the structural integrity of MHC multimer reagents is crucial before use, particularly with limited or irreplaceable samples, but robust controls are often unavailable.

Purpose of the Study:

  • To develop and validate a method for probing the structural integrity of MHC multimers.
  • To enable quality control of MHC multimer reagents prior to their use in critical immunological studies.

Main Methods:

  • A capture assay was designed using beads coated with anti-mouse immunoglobulin (Ig).
  • These beads were incubated with conformation-specific mouse monoclonal antibodies, followed by fluorescently tagged MHC multimers.
  • The capture efficiency of labeled multimers by the beads was measured semi-quantitatively using flow cytometry.

Main Results:

  • The developed method allows for the visualization of correct MHC multimer folding.
  • It enables semi-quantitative comparison of different batches of MHC multimers for quality control.
  • The assay can assess the fidelity of MHC multimer structure, including interactions between heavy chain, peptide, and β2M, depending on antibody availability.

Conclusions:

  • This novel capture assay provides a reliable method to assess MHC multimer structural integrity.
  • It is particularly valuable for studies involving precious or irreplaceable samples, such as patient samples in clinical trials.
  • The approach enhances the reliability of T cell response visualization using MHC:peptide multimers.

Related Concept Videos